Lisa Flammini

1.1k total citations
45 papers, 887 citations indexed

About

Lisa Flammini is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Lisa Flammini has authored 45 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Immunology and 8 papers in Pharmacology. Recurrent topics in Lisa Flammini's work include Receptor Mechanisms and Signaling (14 papers), Mast cells and histamine (10 papers) and Axon Guidance and Neuronal Signaling (4 papers). Lisa Flammini is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Mast cells and histamine (10 papers) and Axon Guidance and Neuronal Signaling (4 papers). Lisa Flammini collaborates with scholars based in Italy, Germany and South Africa. Lisa Flammini's co-authors include Elisabetta Barocelli, Simona Bertoni, Vigilio Ballabeni, Ruggero Bettini, Massimiliano Tognolini, Lisa Elviri, Carmine Giorgio, Annalisa Bianchera, Carlo Bergonzi and Sonya Mros and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Lisa Flammini

44 papers receiving 874 citations

Peers

Lisa Flammini
Lisa Flammini
Citations per year, relative to Lisa Flammini Lisa Flammini (= 1×) peers Subhadeep Roy

Countries citing papers authored by Lisa Flammini

Since Specialization
Citations

This map shows the geographic impact of Lisa Flammini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Flammini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Flammini more than expected).

Fields of papers citing papers by Lisa Flammini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Flammini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Flammini. The network helps show where Lisa Flammini may publish in the future.

Co-authorship network of co-authors of Lisa Flammini

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Flammini. A scholar is included among the top collaborators of Lisa Flammini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Flammini. Lisa Flammini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flammini, Lisa, et al.. (2025). P0054 Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses. Journal of Crohn s and Colitis. 19(Supplement_1). i412–i412. 1 indexed citations
2.
Flammini, Lisa, Federica Vacondio, Federica Gaiani, et al.. (2025). Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions. International Journal of Pharmaceutics. 685. 126228–126228.
3.
Monica, Silvia La, Federica Vacondio, Alessio Lodola, et al.. (2024). Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models. Scientific Reports. 14(1). 6491–6491. 5 indexed citations
4.
Flammini, Lisa, Massimiliano Tognolini, Elisabetta Barocelli, et al.. (2020). Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats. Journal of Controlled Release. 323. 412–420. 25 indexed citations
5.
Grandi, Andrea, Carmine Giorgio, Massimiliano Tognolini, et al.. (2019). Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBD. Frontiers in Pharmacology. 10. 691–691. 18 indexed citations
6.
Monica, Silvia La, Roberta Minari, Daniele Cretella, et al.. (2019). Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC. Journal of Experimental & Clinical Cancer Research. 38(1). 222–222. 54 indexed citations
7.
Intini, Claudio, Lisa Elviri, Jaydee D. Cabral, et al.. (2018). 3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats. Carbohydrate Polymers. 199. 593–602. 180 indexed citations
8.
Monica, Silvia La, Daniele Cretella, Mara Bonelli, et al.. (2017). Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines. Journal of Experimental & Clinical Cancer Research. 36(1). 174–174. 67 indexed citations
9.
Flammini, Lisa, Valentina Vivo, Paolo Colombo, et al.. (2016). Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats. Journal of Controlled Release. 239. 203–210. 13 indexed citations
10.
Matera, Carlo, Lisa Flammini, Marta Quadri, et al.. (2014). Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: Synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity. European Journal of Medicinal Chemistry. 75. 222–232. 25 indexed citations
12.
Giorgio, Carmine, Lisa Flammini, Elisabetta Barocelli, et al.. (2011). Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. PLoS ONE. 6(3). e18128–e18128. 68 indexed citations
13.
Brullo, Chiara, Paola Fossa, Elena Cichero, et al.. (2011). Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. Bioorganic & Medicinal Chemistry Letters. 22(2). 1125–1129. 21 indexed citations
14.
Bordi, Fabrizio, Silvia Rivara, Caterina Carmi, et al.. (2011). Dibasic biphenyl H3 receptor antagonists: Steric tolerance for a lipophilic side chain. European Journal of Medicinal Chemistry. 48. 214–230. 9 indexed citations
15.
Bertoni, Simona, Vigilio Ballabeni, Lisa Flammini, et al.. (2008). Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles. Neurogastroenterology & Motility. 20(11). 1234–1242. 13 indexed citations
16.
Rivara, Mirko, Silvia Rivara, Fabrizio Bordi, et al.. (2008). Synthesis and structure–activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. Bioorganic & Medicinal Chemistry. 16(23). 9911–9924. 27 indexed citations
17.
Vacondio, Federica, Claudia Silva, Marco Mor, et al.. (2007). Development and validation of a LC–MS method with electrospray ionization for the determination of the imidazole H3 antagonist ROS203 in rat plasma. Journal of Pharmaceutical and Biomedical Analysis. 46(1). 200–205. 1 indexed citations
18.
Bertoni, Simona, et al.. (2006). In vitro pharmacology at human histamine H3 receptors and brain access of non-imidazole alkylpiperidine derivatives. Pharmacological Research. 55(2). 111–116. 6 indexed citations
19.
Rivara, Mirko, Silvia Rivara, Fabrizio Bordi, et al.. (2006). Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold. Bioorganic & Medicinal Chemistry Letters. 16(15). 4063–4067. 19 indexed citations
20.
Barocelli, Elisabetta, et al.. (2005). Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: Preliminary pharmacological investigation. Pharmacological Research. 53(3). 226–232. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026